China's enduring commitment to peaceful development: a consistent path across past, present, and future
BEIJING, Oct. 20, 2025 /PRNewswire/ -- A report from People's Daily: Amid a turbulent and rapidly evolving global landscape, one principle remains consistent in China's international engagement: its unwavering commitment to peaceful development....
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key...
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the...
Razor Labs Expands Predictive Maintenance Coverage in Australia with Mobile Fleet AI Solution Launch at IMARC 2025
The company introduces its proven Mobile Fleet Predictive Maintenance solution to Australia, completing its full-suite offering for mining reliability. SYDNEY, Oct. 20, 2025 /PRNewswire/ -- Razor Labs (TASE: RZR), a global leader in AI-driven...
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a...
HARMONi-6 dаta: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet
Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged...
United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits
The company launched American R&D in 2013 and American commercial operations in 2018; in 2020 it opened a 100,000 square foot production and training center in Houston, and just tripled its local footprint to support strong growth. HOUSTON, Oct....
SingPost Launches Residential Posting Box Trial to Bring Postal Services Closer to Home
Drives Partnerships to Enhance Network for Greater Agility and Customer Convenience SingPost's service touchpoints expands to 2500 SINGAPORE, Oct. 19, 2025 /PRNewswire/ -- Singapore Post Limited (SingPost) is strategically positioning its national...
The Grand Opening of 2025 Chery Global Innovation Conference: Gathering Global Wisdom, Driving the Future with Innovation
WUHU, China, Oct. 18, 2025 /PRNewswire/ -- On October 18, 2025, the 2025 Chery Global Innovation Conference officially kicked off under the theme "Innovation • Leading the World with Intelligence." The conference systematically presented Chery...
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...